Cell by Cell Mapping of the Cancer Transcriptome
Capturing Tumor Heterogeneity for Better Therapeutics and Diagnostics
Scaledown Keeps Processes on the Up and Up
Minireactors, Sampling Techniques, and Statistical Analyses Can Keep Optimization Conversations Going
Streamlining Stem Cell Manufacturing
The Factory System Will Help the Stem Cell Industry Standardize, Integrate, and Automate Unit Operations
More Tooth, More Tail in CRISPR Operations
The Most Interesting Thing about CRISPR/Cas9 Is What It Can Accomplish in the Hands of Gifted Researchers
For full access to this article login to GEN Select now.
Driving Successful Assay Development
Host of Therapeutic Classes Require Continuous Updating of Technology
- Since biological therapeutics are derived from living organisms, their manufacture and validation presents difficulties not encountered during traditional small molecule drug development. Despite the complexities inherent in developing biologics, there are a growing number of licensed biological products on the market. IBC’s “Bioassay and Development” meeting held earlier ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.